Undifferentiated connective tissue disease epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Undifferentiated connective tissue disease}}
{{Undifferentiated connective tissue disease}}
{{CMG}} {{AE}}
{{CMG}} {{AE}}{{ADS}}


==Overview==
==Overview==


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
* There is absence of any epidemiological study till date regarding UTCD but its estimated that UCTD represents 60% of the disease with undifferentiated onset.<ref name="pmid18068858">{{cite journal |vauthors=Mosca M, Tani C, Bombardieri S |title=Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology |journal=Best Pract Res Clin Rheumatol |volume=21 |issue=6 |pages=1011–23 |date=December 2007 |pmid=18068858 |doi=10.1016/j.berh.2007.09.004 |url=}}</ref>
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.


===Prevalence===
Mental disorders may be relevant<ref name="pmid18600035">{{cite journal| author=Dobkin PL, Filipski M, Looper K, Schieir O, Baron M, McGill Early Arthritis Research Group| title=Identifying target areas of treatment for depressed early inflammatory arthritis patients. | journal=Psychother Psychosom | year= 2008 | volume= 77 | issue= 5 | pages= 298-305 | pmid=18600035 | doi=10.1159/000142522 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18600035  }} </ref><ref name="pmid19132790">{{cite journal| author=Schieir O, Thombs BD, Hudson M, Taillefer S, Steele R, Berkson L | display-authors=etal| title=Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change. | journal=J Rheumatol | year= 2009 | volume= 36 | issue= 2 | pages= 231-9 | pmid=19132790 | doi=10.3899/jrheum.080147 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19132790  }} </ref>.
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
===Region===
*The majority of [disease name] cases are reported in [geographical region].
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
===Developed Countries===
===Developing Countries===
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 04:14, 18 August 2021

Undifferentiated connective tissue disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Undifferentiated connective tissue disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other imaging findings

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Undifferentiated connective tissue disease epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Undifferentiated connective tissue disease epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Undifferentiated connective tissue disease epidemiology and demographics

CDC on Undifferentiated connective tissue disease epidemiology and demographics

Undifferentiated connective tissue disease epidemiology and demographics in the news

Blogs on Undifferentiated connective tissue disease epidemiology and demographics

Directions to Hospitals Treating Undifferentiated connective tissue disease

Risk calculators and risk factors for Undifferentiated connective tissue disease epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Epidemiology and Demographics

  • There is absence of any epidemiological study till date regarding UTCD but its estimated that UCTD represents 60% of the disease with undifferentiated onset.[1]

Mental disorders may be relevant[2][3].

References

  1. ↑ Mosca M, Tani C, Bombardieri S (December 2007). "Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology". Best Pract Res Clin Rheumatol. 21 (6): 1011–23. doi:10.1016/j.berh.2007.09.004. PMID 18068858.
  2. ↑ Dobkin PL, Filipski M, Looper K, Schieir O, Baron M, McGill Early Arthritis Research Group (2008). "Identifying target areas of treatment for depressed early inflammatory arthritis patients". Psychother Psychosom. 77 (5): 298–305. doi:10.1159/000142522. PMID 18600035.
  3. ↑ Schieir O, Thombs BD, Hudson M, Taillefer S, Steele R, Berkson L; et al. (2009). "Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change". J Rheumatol. 36 (2): 231–9. doi:10.3899/jrheum.080147. PMID 19132790.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Undifferentiated_connective_tissue_disease_epidemiology_and_demographics&oldid=1711477"